UM researchers make breakthrough to treat form of leukemia
In part due to research by two University of Michigan researchers, a form of leukemia can be treated more easily through an FDA-approved drug.
Source...
Cancer treatment breakthrough uses tiny metal particles to target tumours
Your support helps us to tell the storyFrom reproductive rights to climate change to Big Tech, The Independent is on the ground when the...
2025 was a year of breakthroughs in health and medicine. Here...
It was a tumultuous year in the world of health, marked by a resurgence of measles in Canada and budget cuts to research and...
New Advances in AML Treatment
In the relentless pursuit of novel cancer therapies, an age-old natural remedy is stepping into the scientific spotlight with unprecedented vigor. Recent breakthroughs in...
FDA Grants Breakthrough Therapy Designation to T-DXd Early HER2+ BC |...
The FDA has granted breakthrough therapy designation (BTD) to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the treatment of adult patients with HER2-positive early breast...
These medical breakthroughs and advances gave patients new hope in 2025
Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized gene therapy and more.
Source link
T-DXd Granted Breakthrough Therapy Designation in Post-Neoadjuvant HER2-Positive Early Breast Cancer
Fam-trastuzumab deruxtecan-nxki (T-DXd, Enhertu; Daiichi Sankyo, Inc., AstraZeneca), an antibody-drug conjugate (ADC), has been granted breakthrough therapy designation by the FDA as a...
2025 brings breakthroughs in Alzheimer’s diagnosis and treatment
For the millions of Americans touched by Alzheimer’s disease, 2025 brought major advances in the understanding of brain health and progress in diagnosis and...
FDA Gives Breakthrough Therapy Designation to Post-Neoadjuvant T-DXd for HER2+ Early...
The FDA has granted breakthrough therapy designation to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the post-neoadjuvant treatment of adult patients with HER2-positive early breast...
Gene-Editing Breakthrough Ends Transfusions for UK Patient
UK doctors have delivered a one-time CRISPR therapy to free a woman with beta thalassaemia from lifelong blood transfusions.
Source link